17
References
1. Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, et al.
Rheumatoid arthritis disease activity measures: American College of Rheumatolog y
recommendations for use in clinical practice. Arthritis Care Res. (Hoboken).
2012;64(5):640-647.
2. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The
American Rheumatism Association 1987 revised criteria for the classification of
rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-24.
3. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. 2010
Rheumatoid arthritis classification criteria: an American College of Rheumatolog y/
European League Against Rheumatism collaborative initiative. Arthritis Rheum.
2010;62(9):2569-81.
4. Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American
College of Rheumatolog y/European League Against Rheumatism provisional
definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum.
2011;63(3):573-86.
5. Hurst JW, Morris DC, Alexander RW. The use of the New York Heart Association's
classification of cardiovascular disease as part of the patient's complete Problem List.
Clin Cardiol. 1999;22(6):385-90.
6. Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van
Denderen JC, et al. Randomised comparison of combined step-down prednisolone,
methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid
arthritis. Lancet. 1997;350(9074):309-18.
7. Wolfe F, Michaud K, Pincus T. A composite disease activity scale for clinical practice,
observational studies, and clinical trials: the patient activity scale (PAS/PAS-II).
J Rheumatol. 2005;32(12):2410-5.
8. Pincus T, Yazici Y, Bergman M. A practical guide to scoring a Multi-Dimensional
Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient
Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care,
without rulers, calculators, websites or computers. Best Pract Res Clin Rheumatol.
2007;21(4):755-87.
9. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase
reactants add little to composite disease activity indices for rheumatoid arthritis:
validation of a clinical activity score. Arthritis Research & Therapy. 2005;7(4):R796-
806.
10. Fransen J, Stucki G, Van Riel P. Disease Activity Score (DAS), Disease Activity
Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatolog y
(RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI). Arthritis
Rheum. 2003;49(S5):S214-S224.
11. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified
disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatolog y
(Oxford). 2003;42(2):244-57.
12. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American
College of Rheumatolog y 2008 recommendations for the use of nonbiologic and
biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis
Rheum. 2008;59(6):762-84.
13. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012
update of the 2008 American College of Rheumatolog y recommendations for the
use of disease-modifying antirheumatic drugs and biologic agents in the treatment of
rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64:625-39.
14. Source: http://www.cdc.gov/vaccines/vpd-vac/pneumo/default.htm?s_cid=cs_797
